Healthequity (NASDAQ:HQY) Upgraded to “Hold” at BidaskClub

BidaskClub upgraded shares of Healthequity (NASDAQ:HQY) from a sell rating to a hold rating in a research note published on Wednesday, BidAskClub reports.

A number of other brokerages have also recently commented on HQY. Citigroup reissued a buy rating on shares of Healthequity in a research note on Friday, June 28th. Zacks Investment Research raised shares of Healthequity from a strong sell rating to a hold rating in a research note on Tuesday, May 21st. KeyCorp lowered their price objective on shares of Healthequity from $90.00 to $70.00 and set an overweight rating on the stock in a research note on Tuesday, September 17th. TheStreet cut shares of Healthequity from a b rating to a c+ rating in a research note on Tuesday, September 3rd. Finally, JPMorgan Chase & Co. set a $80.00 price objective on shares of Healthequity and gave the company an overweight rating in a research note on Wednesday, June 5th. Three research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of Buy and a consensus target price of $78.92.

Shares of NASDAQ HQY opened at $60.89 on Wednesday. The stock has a market cap of $4.36 billion, a price-to-earnings ratio of 53.73, a PEG ratio of 3.57 and a beta of 1.55. Healthequity has a 52 week low of $50.29 and a 52 week high of $101.58. The company’s 50-day moving average price is $63.87 and its 200 day moving average price is $69.82. The company has a current ratio of 22.98, a quick ratio of 22.98 and a debt-to-equity ratio of 0.04.

Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 3rd. The company reported $0.36 EPS for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.10. The firm had revenue of $86.60 million for the quarter, compared to analysts’ expectations of $85.33 million. Healthequity had a net margin of 28.13% and a return on equity of 11.77%. The firm’s revenue was up 21.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.36 EPS. As a group, research analysts expect that Healthequity will post 0.87 earnings per share for the current year.

In other Healthequity news, EVP Delano Ladd sold 6,875 shares of the company’s stock in a transaction dated Monday, July 22nd. The shares were sold at an average price of $80.00, for a total value of $550,000.00. Following the transaction, the executive vice president now directly owns 17,833 shares in the company, valued at approximately $1,426,640. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $60.82, for a total transaction of $243,280.00. Following the completion of the transaction, the chief financial officer now owns 50,100 shares in the company, valued at $3,047,082. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,899 shares of company stock worth $2,464,691. 3.70% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in HQY. BlackRock Inc. lifted its holdings in shares of Healthequity by 13.1% during the 2nd quarter. BlackRock Inc. now owns 7,268,685 shares of the company’s stock worth $475,373,000 after acquiring an additional 840,177 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Healthequity by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 5,646,295 shares of the company’s stock worth $369,268,000 after acquiring an additional 138,020 shares during the period. Invesco Ltd. lifted its holdings in shares of Healthequity by 13.7% during the 2nd quarter. Invesco Ltd. now owns 2,140,851 shares of the company’s stock worth $140,012,000 after acquiring an additional 258,769 shares during the period. Janus Henderson Group PLC lifted its holdings in shares of Healthequity by 13.9% during the 2nd quarter. Janus Henderson Group PLC now owns 2,057,831 shares of the company’s stock worth $134,582,000 after acquiring an additional 250,692 shares during the period. Finally, Wasatch Advisors Inc. lifted its holdings in shares of Healthequity by 22.6% during the 1st quarter. Wasatch Advisors Inc. now owns 2,038,929 shares of the company’s stock worth $150,840,000 after acquiring an additional 376,461 shares during the period. Institutional investors own 94.19% of the company’s stock.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Story: Why do commodities matter?

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.